If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> DERMATOLOGY<br /> EMJ Dermatol. 2019 Suppl 2 • europeanmedical-journal.com<br /> INSIDE<br /> Dimethyl Fumarate in<br /> Psoriasis Therapy<br /> Dimethyl Fumarate in Psoriasis Therapy<br /> This meeting took place on 12th October 2018, as part of<br /> the 2nd European Workshop on Skin Immune Mediated<br /> Inflammatory Diseases (SIMID) in Verona, Italy<br /> Speakers: Peter Weisenseel<br /> Dermatologikum, Hamburg, Germany<br /> Disclosure: Dr Weisenseel is a speaker, investigator, and advisor for Almirall, Biogen Idec,<br /> and other pharmaceutical companies that produce or distribute drugs for psoriasis,<br /> including Abbvie, BMS, Celgene, LeoPharma, Janssen, Eli Lilly, Novartis, Medac,<br /> Dexcel, Böhringer, Pfizer, and MSD.<<a title="EMJ Dermatol. 2019 Suppl 2 page 1" href="http://viewer.zmags.com/publication/39fe1be2?page=1"> DERMATOLOGY EMJ Dermatol. 2019 Suppl 2 • european</a> <a title="EMJ Dermatol. 2019 Suppl 2 page 2" href="http://viewer.zmags.com/publication/39fe1be2?page=2"> Dimethyl Fumarate in Psoriasis Therapy This meet</a> <a title="EMJ Dermatol. 2019 Suppl 2 page 3" href="http://viewer.zmags.com/publication/39fe1be2?page=3"> Cambridge, Massachusetts, USA), for multiple </a> <a title="EMJ Dermatol. 2019 Suppl 2 page 4" href="http://viewer.zmags.com/publication/39fe1be2?page=4"> Patients achieving PASI 75 (%) 45 40 35 30</a> <a title="EMJ Dermatol. 2019 Suppl 2 page 5" href="http://viewer.zmags.com/publication/39fe1be2?page=5"> term therapy.19 Recommendations for avoiding flush</a> <a title="EMJ Dermatol. 2019 Suppl 2 page 6" href="http://viewer.zmags.com/publication/39fe1be2?page=6"> References 1. Das deutsche Psoriasis-Registe</a>